Building safety into CAR-T therapy

Daniel T Peters, Barbara Savoldo, Natalie S Grover · 2023

Read Building safety into CAR-T therapy by Daniel T Peters, Barbara Savoldo, Natalie S Grover (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10760383.txt.

Description

Chimeric antigen receptor T cell (CAR-T) therapy is an innovative immunotherapeutic approach that utilizes genetically modified T-cells to eliminate cancer cells using the specificity of a monoclonal antibody (mAb) coupled to the potent cytotoxicity of the T-lymphocyte. CAR-T therapy has yielded significant improvements in relapsed/refractory B-cell malignancies.

Catalog record

CREATORDaniel T Peters, Barbara Savoldo, Natalie S Grover
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10760383

Browse the full library · About the Tower of Babel